|
Home
>
Newsletters
>
Washington Drug Letter
> Contraceptive Sales Could Rise With No-Copay Final Rule
Washington Drug Letter
Jan. 30, 2012
| Vol.
44 No.
5
Contraceptive Sales Could Rise With No-Copay Final Rule
Contraceptive sales could climb this summer as an HHS final rule requires most health insurance plans to cover preventive services for women, without charging co-pays, beginning Aug. 12.
|
Related Articles
Long-Awaited FDA Final Rule Rejects Parental Consent Waivers for TrialsJustice Official: Understand What Ammunition Sunshine Might Provide Enforcement, Consider Voluntary DisclosuresNo Sunshine in 2012: CMS Pushes Back Drugmaker Data Collection … Again Beefed-Up Rule on Investigator Disqualification Takes Effect in May
|
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews
All rights reserved. Do not duplicate or redistribute in any form.